Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50–85 years
Jody Lawrence, Nicholas Kitchin, Annaliesa S. Anderson, Michael W. Pride, Kathrin U. Jansen, William C. Gruber, Yahong Peng, Kevin Yi, Charles Knirsch, Chris Webber
Topics & Concepts
MedicineToxoidPlaceboRegimenClostridium difficileAdverse effectImmunogenicityTolerabilityInternal medicineImmunologyVaccinationGastroenterologyTetanusAntibodyAntibioticsMicrobiologyBiologyPathologyAlternative medicineClostridium difficile and Clostridium perfringens researchBotulinum Toxin and Related Neurological DisordersGastrointestinal motility and disorders